Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDH1 | O75874 | 6/20 | 0.33 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.31 |
| ▸ | IDO1 | P14902 | 1/20 | 0.31 |
| ▸ | TDO2 | P48775 | 1/20 | 0.31 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25254474 | 0.96 | IDH1 (0.31) | IDH1IDO1TDO2 | |
| SCHEMBL20606916 | 0.90 | TSHR (0.36) | IDH1EPHX2 | |
| SCHEMBL7028275 | 0.90 | TSHR (0.36) | IDH1EPHX2 | |
| SCHEMBL28643647 | 0.89 | LMNA (0.33) | IDH1 | |
| SCHEMBL3375353 | 0.89 | MGAM (0.32) | IDO1TDO2 | |
| SCHEMBL19436038 | 0.88 | MGAM (0.40) | EPHX2 | |
| SCHEMBL3867901 | 0.88 | MGAM (0.40) | EPHX2 | |
| SCHEMBL3871745 | 0.88 | MGAM (0.40) | EPHX2 | |
| SCHEMBL12332966 | 0.88 | MGAM (0.40) | EPHX2 | |
| SCHEMBL233611 | 0.88 | MGAM (0.40) | EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100034766-A1 | Malodor Counteracting Compositions | GIVAUDAN SA (CH) | 2010-02-11 | — | — | US | claimed |
| EP-2079487-A1 | MALODOR COUNTERACTING COMPOSITIONS | Givaudan SA (CH) | 2009-07-22 | — | — | EP | claimed |
| WO-2008049257-A1 | MALODOR COUNTERACTING COMPOSITIONS | GIVAUDAN SA (CH) | 2008-05-02 | — | — | WO | claimed |
| EP-3122713-B1 | PROCESS FOR THE PRODUCTION OF 1-(5,5-DIMETHYLCYCLOHEX-1-EN-1-YL)ETHANONE AND 1-(5,5-DIMETHYLCYCLOHEX-6-EN-1-YL)ETHANONE | DSM IP ASSETS BV (NL) | 2019-04-24 | — | — | EP | disclosed |
| US-10005710-B2 | Process of production of 1-(5,5-dimethylcyclohex-1-en-1-yl)ethanone and 1-(5,5-dimethylcyclohex-6-en-1-yl )ethanone | DSM IP ASSETS B.V. (NL) | 2018-06-26 | — | — | US | disclosed |
| US-10005710-B2 | Process of production of 1-(5,5-dimethylcyclohex-1-en-1-yl)ethanone and 1-(5,5-dimethylcyclohex-6-en-1-yl )ethanone | DSM IP ASSETS B.V. (NL) | 2018-06-26 | — | — | US | disclosed |
| US-20170217864-A1 | PROCESS OF PRODUCTION OF 1-(5,5-DIMETHYLCYCLOHEX-1-EN-1-YL)ETHANONE AND 1-(5,5-DIMETHYLCYCLOHEX-6-EN-1-YL )ETHANONE | DSM IP ASSETS B.V. (NL) | 2017-08-03 | — | — | US | disclosed |
| US-20170217864-A1 | PROCESS OF PRODUCTION OF 1-(5,5-DIMETHYLCYCLOHEX-1-EN-1-YL)ETHANONE AND 1-(5,5-DIMETHYLCYCLOHEX-6-EN-1-YL )ETHANONE | DSM IP ASSETS B.V. (NL) | 2017-08-03 | — | — | US | disclosed |
| WO-2015144832-A1 | PROCESS OF PRODUCTION OF 1-(5,5-DIMETHYLCYCLOHEX-1-EN-1-YL)ETHANONE AND 1-(5,5-DIMETHYLCYCLOHEX-6-EN-1-YL)ETHANONE | DSM IP ASSETS B.V. (NL) | 2015-10-01 | — | — | WO | disclosed |
| US-20100034766-A1 | Malodor Counteracting Compositions | GIVAUDAN SA (CH) | 2010-02-11 | — | — | US | disclosed |
| EP-2079487-A1 | MALODOR COUNTERACTING COMPOSITIONS | Givaudan SA (CH) | 2009-07-22 | — | — | EP | disclosed |
| WO-2008049257-A1 | MALODOR COUNTERACTING COMPOSITIONS | GIVAUDAN SA (CH) | 2008-05-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100034766-A1 | Malodor Counteracting Compositions | MTNR1A, MTNR1B, MC4R | IDH1 4519/4885EPHX2 1508/4885IDO1 2617/4885 |
| US-10005710-B2 | Process of production of 1-(5,5-dimethylcyclohex-1-en-1-yl)ethanone and 1-(5,5-dimethylcyclohex-6-en-1-yl )ethanone | EEF2K, CYP2E1, EIF2AK1 | IDH1 1267/4885EPHX2 736/4885IDO1 944/4885 |
| US-20170217864-A1 | PROCESS OF PRODUCTION OF 1-(5,5-DIMETHYLCYCLOHEX-1-EN-1-YL)ETHANONE AND 1-(5,5-DIMETHYLCYCLOHEX-6-EN-1-YL )ETHANONE | EEF2K, CYP2E1, EIF2AK1 | IDH1 1267/4885EPHX2 736/4885IDO1 944/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.